GLP-1 and Pregnancy: What the Evidence Says

Here’s a combination that catches a lot of people off guard: the same medication that isn’t recommended during pregnancy can also make pregnancy more likely. If you’re on a GLP-1 and you’re thinking about a baby — now, soon, or someday — that tension is worth understanding before it becomes a surprise.

This is educational information, not medical advice. GLP-1 and GLP-1/GIP medicines — including semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), and dulaglutide (Trulicity) — are prescription-only and must be prescribed and supervised by a licensed clinician. Versions sold online as “research use only” are not FDA-approved for human use. Never start, change, or stop a dose on your own, and never source or self-inject these drugs outside of legitimate medical care. Talk to your doctor or pharmacist first, especially if you take other medications, could become pregnant, or have a health condition.

Quick answer: GLP-1 drugs aren’t approved or recommended during pregnancy, and the standard guidance is to stop them before you conceive — or as soon as you know you’re pregnant. At the same time, the weight loss and hormonal shifts these drugs cause can boost fertility, which is exactly why so many “Ozempic babies” arrive unplanned. The limited human data we have so far are reassuring rather than alarming, but they’re not the final word. If you’re planning a pregnancy, the conversation to have with your clinician is about when to stop, not whether.

What is your main goal?

Lose weight Gain muscles Eat healthy Explore new cuisines

Powered by DietGenie

Why these drugs aren’t used in pregnancy

The short version: nobody has the safety data to say they’re fine, so the responsible default is to avoid them.

GLP-1 receptor agonists were never tested in pregnant people during their approval trials — pregnancy is almost always an exclusion criterion in drug studies, for obvious ethical reasons. That leaves two sources of information: animal studies and accidental human exposures. In animal studies, some GLP-1 drugs showed potential harm to fetal development at certain doses. That doesn’t automatically translate to humans, but it’s enough of a flag that regulators and clinicians treat pregnancy as a stop sign rather than a maybe.

There’s also a more basic reason. Pregnancy is not the time to be losing weight or eating dramatically less. A growing fetus needs steady nutrition and a stable maternal environment. GLP-1 drugs work largely by reducing appetite and slowing how fast your stomach empties — useful for weight loss, but not what you want when you’re trying to support a pregnancy. So the recommendation to stop isn’t only about unknown risks; it’s also about what the body actually needs during those nine months.

Suggested read: Ozempic vs Mounjaro: How the Two Compare

The “Ozempic baby” effect

This is the part that surprises people most. You start a GLP-1 to manage weight or blood sugar, and a few months later you’re pregnant — sometimes when you’d assumed pregnancy was unlikely or even off the table.

There are a few mechanisms working together here. Losing a meaningful amount of weight improves insulin sensitivity, and better insulin sensitivity tends to restore more regular ovulation. For people with PCOS, this can be dramatic — irregular or absent cycles that have lasted years can become predictable again, and predictable cycles mean predictable fertile windows. Weight loss on its own also shifts the hormonal picture in ways that favor conception, independent of any direct effect of the drug.

The result is a real, documented pattern: people who weren’t expecting to get pregnant, do. Some had been told for years that their fertility was low. Some weren’t using contraception because they didn’t think they needed it. And some were using contraception — which brings up a wrinkle worth knowing about.

Suggested read: How Long Does Ozempic Take to Work?

Birth control gets complicated too

If you’re on a GLP-1 and you’re not trying to conceive, don’t assume your usual contraception is doing its full job.

Two things can interfere. First, the same fertility boost described above means your baseline odds of pregnancy may be higher than they used to be, so a method that was “good enough” before might feel less reliable now. Second, and more specifically, the way some GLP-1 drugs slow stomach emptying can affect how well oral medications — including the pill — get absorbed, especially around the time you’re increasing your dose. The practical upshot is that the combination of higher fertility and potentially less reliable pill absorption is exactly how unplanned pregnancies happen on these drugs. We go deeper into this in our piece on GLP-1s and birth control, and it’s a genuinely useful read if pregnancy isn’t in your plans right now.

What the human data actually show

Here’s where it helps to separate “we don’t have enough data” from “the data we have look bad.” Those are very different statements, and the distinction matters if you’ve had an accidental exposure and you’re scared.

So far, the human evidence is limited and observational — meaning researchers looked at what happened to people who happened to be exposed, rather than running a controlled trial. With that caveat front and center, the picture is more reassuring than frightening.

A Danish nationwide cohort study looked at women exposed to a GLP-1 receptor agonist around the time of conception. After carefully matching those women to comparable women who weren’t exposed, most obstetric complications were not increased. There was one signal worth understanding: a higher rate of preterm birth, but it showed up only in women who were taking the drug for diabetes — and not in women taking it for weight management. That pattern points the finger at the underlying diabetes (which carries its own pregnancy risks) rather than at the drug itself.¹

A separate narrative review pulled together the available evidence on inadvertent early-pregnancy exposure and reported no significant increase in congenital anomalies — birth defects — among exposed pregnancies. The authors were careful to stress that the evidence base is still limited and observational, so this isn’t a green light. But it’s the kind of finding that should lower the panic level if you’ve conceived while taking one of these drugs.²

None of this means GLP-1 drugs are safe in pregnancy. It means that when exposure has happened by accident, the outcomes studied so far haven’t shown the kind of harm the animal data raised as a possibility. Reassuring, not definitive — both halves of that sentence count.

Suggested read: Switching From Ozempic to Mounjaro: What to Know

Stopping before you try to conceive

If a pregnancy is on your radar, the cleaner approach is to stop the medication ahead of time, with the timing matched to how long the drug lingers in your body.

These drugs have different half-lives — the time it takes for the amount in your system to drop by half — and they need several of those cycles to clear. The narrative review above offered rough guidance based on each drug’s half-life: stop semaglutide at least around 35 days before trying to conceive, tirzepatide somewhere in the range of 25 to 35 days, and liraglutide at least about 3 days before, since it clears much faster.² Treat those as starting points for a conversation, not a prescription you set yourself — your clinician will factor in your specific drug, dose, and situation.

There’s a second layer to plan for, and it’s the one people forget. Stopping a GLP-1 often brings appetite back and can lead to some weight regain, and how you manage that transition matters when you’re about to be pregnant. It’s worth reading our guide on stopping a GLP-1 so the off-ramp doesn’t catch you flat-footed. Ideally you’d time the stop, let your body settle, and head into pregnancy on stable ground rather than mid-swing.

If you’re being treated for diabetes rather than weight alone, don’t just stop — your clinician will likely want to switch you to a medication that’s considered appropriate during pregnancy, because uncontrolled blood sugar carries real risks of its own. That’s a planned handoff, not a cold-turkey halt.

Suggested read: Ozempic and Constipation: Causes and Relief

What to do if you’re already pregnant on a GLP-1

First: don’t panic. That’s not a throwaway reassurance — it’s what the evidence supports. As the data above suggest, accidental exposure early in pregnancy hasn’t been linked to the kind of harm that warrants alarm.

What you should do is stop the medication and contact your doctor promptly. Not next month, not at your next routine appointment — soon, so they can adjust your care, switch any other medications if needed, and set up appropriate monitoring. The combination of “stop now” and “talk to your clinician quickly” covers the practical bases without spiraling into worst-case thinking that the current data don’t justify.

What about breastfeeding?

The pattern here mirrors pregnancy: generally avoided, mostly because the data are thin. We don’t have good information on how much of these drugs passes into breast milk or what that might mean for a nursing infant, so the cautious default is to hold off. As with everything else here, this is a conversation to have with your clinician, who can weigh your particular circumstances rather than apply a blanket rule.

A note on side effects

Setting pregnancy aside for a moment — the everyday side effects of GLP-1 drugs don’t disappear just because you’re thinking about fertility. Nausea, vomiting, and other gastrointestinal effects are common, especially early on and when doses go up.³ Those matter in the pregnancy conversation too, because heavy nausea or vomiting around conception isn’t a great backdrop, and it’s one more reason the “stop and let things settle” approach makes sense.

Bottom line

GLP-1 drugs and pregnancy sit in an awkward spot. They aren’t used during pregnancy — animal data raised concerns, and there’s simply not enough human safety information to recommend them. Yet they make pregnancy more likely by improving fertility, which is how the “Ozempic baby” stories keep happening, sometimes despite birth control. The limited human data on accidental exposure are genuinely reassuring: most obstetric complications haven’t been increased, and no significant rise in birth defects has shown up so far — though the evidence is still observational and not the last word. If you’re planning a pregnancy, work out a stopping plan with your clinician timed to your specific drug. If you find out you’re pregnant while taking one, stop and call your doctor soon — but don’t let fear run the show. The smartest move in every version of this story is the same: have the conversation early, before biology makes the decision for you.